This is a fully human antibody that specifically targets CD4. It has been observed that the antibody does not induce CD4 internalization in either of the tested cell types at the two time points. The CD4 antigen acts as a coreceptor in conjunction with the T cell receptor on T lymphocytes to recognize antigens displayed by antigen-presenting cells in the context of class II MHC molecules. CD4-related diseases include immunodeficiency 79 and Okt4 epitope deficiency.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-039 | Anti-Human CD4 Recombinant Antibody (Zanolimumab) | Neut, ELISA, IF, IP, FuncS, FC, IHC | IgG1 - kappa |
There are currently no Customer reviews or questions for HPAB-0305LY. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.